Brava Diagnostics to Present at Rockies Venture Club Demo Day

Pitch completes the RVC HyperAccelerator Program

Brava Diagnostics, Inc., a company transforming acute care diagnostics with a next generation point-of-care platform, announced today that the Byron Hewett, CEO, will present at the Rockies Venture Club HyperAccelerator Demo Day. The event will be held on January 27, 2-5 PM at TrueSpace, 4600 S Ulster St #1450 in Denver.

 “RVC HyperAccelerator graduates have developed a deep and coherent set of strategies with all the crucial steps in place to be ready for investment, all packaged into a compelling 5-minute pitch.”

Peter Adams, Executive Director of Rockies Venture Club

Angel investors, venture capitalists and the public will have a chance to see pitches from nine investment-ready companies and to meet after the pitches to discuss the opportunities with other investors. The Investor Breakout that follows the pitches is open to Accredited Investors.

Brava is developing a next generation blood test for heart attack: a point-of-care, high-sensitivity troponin test to assess patients with chest pain in 15 minutes. Rapid triage is critical to saving lives and improving quality of care in the emergency department. High-sensitivity troponin tests have demonstrated more efficient diagnosis and rule-out of heart attack. Rapid rule-out and safe discharge of low-risk patients eases crowding in the emergency department and reduces hospital admissions. Savings to the healthcare system are estimated at over $7 billion annually in the United States.

Carrie Mulherin, Brava Co-Founder and CMO commented, “The HyperAccelerator curriculum and interaction with mentors helped us to simplify and clarify our story and fill some gaps in our financial analysis tool box. I highly recommend the program to entrepreneurs looking to elevate their game another level.”

About Brava Diagnostics
Brava is developing a NextGen blood test for heart attack for the emergency department. Our first product is a point-of-care high-sensitivity troponin test to assess patients with chest pain to guide treatment decisions or safe discharge. The Brava test delivers lab-quality results in 15 minutes, which means faster diagnosis and treatment of heart attack and faster rule-out/safe discharge of low-risk patients. Rapid rule-out eases crowding in the ED, reduces the number of admissions, improves resource utilization and reduces costs to the healthcare system. Learn more at www.bravadx.com

About Rockies Venture Club
The Rockies Venture Club is an angel investing group dedicated to accelerating economic development by educating and connecting investors and entrepreneurs. RVC holds over 100 events per year throughout Colorado. These include monthly pitch events, angel investor forums, group mastermind meetings, and two major conferences that bring together over 300 community members each. www.rockiesventureclub.org